NSE · VENUSREM
Venus Remedies Limited
₹1,782.10
+3.05%
Market Cap
2,382.67 Cr
P/E Ratio
23.18
P/B Ratio
3.59
ROE
15.48%
ROCE
19.39%
Dividend Yield
0.56%
52W High
₹1,815.70
52W Low
₹424.00
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 |
|---|---|---|
| Revenue | 178.86 Cr | 259.40 Cr |
| Net Profit | 22.97 Cr | 47.49 Cr |
| EPS | 17.18 | 35.53 |
| Operating Profit | 30.04 Cr | 61.61 Cr |
Shareholding pattern
Promoter
41.76%
Public
58.24%
FII
—
DII
—
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 07 Aug 2026 | Dividend | Dividend - Rs 10 Per Share |
| 13 Sep 2024 | Other | Annual General Meeting |
| 17 Aug 2023 | Other | Annual General Meeting |
| 11 Aug 2022 | Other | Annual General Meeting |
| 09 Sep 2021 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.